Hematopoietic Stem Cell TransplantationTransplantation, HomologousGraft vs Host DiseaseStem Cell TransplantationTransplantation ConditioningTransplantation, AutologousHematologic NeoplasmsPeripheral Blood Stem Cell TransplantationHistocompatibility TestingHepatic Veno-Occlusive DiseaseHematopoietic Stem CellsStem CellsTreatment OutcomeBone Marrow TransplantationTransplantation ChimeraImmunosuppressive AgentsTissue DonorsImmunocompromised HostRetrospective StudiesMyeloablative AgonistsGraft vs Leukemia EffectBusulfanRecurrenceRemission InductionGraft SurvivalLeukemiaVidarabineGraft vs Tumor EffectLiver TransplantationCord Blood Stem Cell TransplantationMultiple MyelomaWhole-Body IrradiationCombined Modality TherapyStem Cell NicheLymphocyte TransfusionLeukemia, Myeloid, AcuteMesenchymal Stem Cell TransplantationHistocompatibilityAntigens, CD34Cell DifferentiationSiblingsHLA AntigensAnemia, AplasticTransplantationSurvival AnalysisLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSalvage TherapyAdult Stem CellsDisease-Free SurvivalCell TransplantationMelphalanSurvival RateCytomegalovirus InfectionsLymphocyte DepletionKidney TransplantationHematopoiesisMyelodysplastic SyndromesAntilymphocyte SerumMinor Histocompatibility AntigensEmbryonic Stem CellsHematopoietic Stem Cell MobilizationChimerismPrecursor Cell Lymphoblastic Leukemia-LymphomaTime FactorsFollow-Up StudiesCyclophosphamideNeoplasm, ResidualAntineoplastic Combined Chemotherapy ProtocolsVirus ActivationMice, Inbred C57BLBone Marrow CellsTransplantation ImmunologyT-LymphocytesFlow CytometryBone MarrowAcute DiseaseHematologic DiseasesCell LineageGraft RejectionImmunosuppressionPancytopeniaCytomegalovirusCells, CulturedHeart TransplantationTransplantation, IsogeneicPrognosisPluripotent Stem CellsCytarabineFetal BloodCell ProliferationPrimary MyelofibrosisGranulocyte Colony-Stimulating FactorLymphoma, Non-HodgkinLung TransplantationHodgkin DiseaseLeukemia, MyeloidNeural Stem CellsMesenchymal Stromal CellsLymphoproliferative DisordersAntineoplastic Agents